SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
← All insights
Market Move

Why Is Liquidia Corporation (LQDA) Up 7% Today?

Healthcare's biggest mover today

Last updated: October 26, 2026, 5:30 PM ET· LQDA profile

Liquidia Corporation is the biggest Healthcare gainer on the board today. What follows is what can be sourced about why — and, where nothing can be, that is said plainly rather than filled in.

At a glance
Move today
+7.5%
Price
$42.65
Market cap
$3.82 billion
Volume vs average
1.2x
52-week high
$93.61
52-week low
$22.05
Source: Market data · InsiderBuying.com

The move

LQDA trades at $42.65, up +7.5% on the session, with a market capitalisation of $3.82 billion.

Volume is 1.2 times the 30-day average, which is the part of a move that tells you whether anyone turned up for it.

Against its 52-week range of $22.05 to $93.61, today's price sits 29% of the way up it.

At a glance
Move today
+7.5%
Price
$42.65
Market cap
$3.82 billion
Volume vs average
1.2x
52-week high
$93.61
52-week low
$22.05
Source: Market data · InsiderBuying.com

What can be sourced

The record shows 1 analyst action in the last fortnight, the most recent from Julian Harrison at a $70.00 target on October 14th, 2026.

None of that is proof of causation. A filing or a target change that lands near a move is context, and the market routinely moves on neither.

What it does do is separate a move with something behind it from one with nothing.

The data
MetricValueContext
Change today+7.5%Healthcare average -0.7%
Volume3,779,7401.2x the 30-day average
Market cap$3.82 billionMedical - Pharmaceuticals
Range$22.05 – $93.6152 weeks
Source: Market data · InsiderBuying.com

What insiders have been doing

10 open-market insider transactions are on file for the last 90 days.

Insider activity before a move is the one piece of context that carries money behind it rather than an opinion.

It is also disclosed late, so proximity to today's move should not be read as foreknowledge.

The filings
  • October 12th, 2026sellBoyle Dana · Other$167,804Form 4
  • October 12th, 2026sellJEFFS ROGER · CEO$932,549Form 4
  • October 12th, 2026sellKaseta Michael · CFO$539,354Form 4
  • October 12th, 2026sellKhindri Sanjeev · Other$31,356Form 4
  • October 12th, 2026sellKrepp Sarah · Other$149,378Form 4
  • October 12th, 2026sellMoomaw Scott · Other$252,418Form 4
  • October 12th, 2026sellSaggar Rajeev · Other$262,529Form 4
  • October 12th, 2026sellSchundler Russell · Other$389,948Form 4
  • October 12th, 2026sellAdair Jason · Other$207,932Form 4
  • October 5th, 2026sellBloch Stephen M · Director$6.39 millionForm 4
Source: SEC Form 4 filings · InsiderBuying.com
The data
MetricValueContext
Change today+7.5%Healthcare average -0.7%
Volume3,779,7401.2x the 30-day average
Market cap$3.82 billionMedical - Pharmaceuticals
Range$22.05 – $93.6152 weeks
Source: Market data · InsiderBuying.com

The bottom line

A move with something on the record behind it. Whether it holds is a different question. Not investment advice. Summarized from public SEC Form 4 and congressional disclosure data and analyst ratings data.